HOME >> BIOLOGY >> NEWS
First-Ever Scientific Estimate Of Total Bacteria On Earth Shows Far Greater,,Numbers Than Ever Known Before

40 miles high in the atmosphere and beneath the ocean floor some seven miles deep..

In order to estimate the total number of bacteria on Earth, the group at Georgia divided the Earth into several areas, including oceanic and other aquatic environments, the soil, the subsurface of soil, and other habitats such as the air, inside animals and on the surface of leaves. The study brought some surprises.

"By combining direct measurements of the number of prokaryotic cells in various habitats, we found the total number of cells was much larger than we expected," said Whitman.

After making a list of known habitats for bacteria, the group searched scientific literature for direct measurements of cell numbers and the amount of carbon in cells from these habitats. They found that the great majority of bacteria are in sea water, soil, and oceanic and soil subsurface and so began to examine these habitats further.

Numerous direct measurements have been made for the total number of bacteria in the oceans, and median values were chosen to represent the three major oceanic habitats: the upper 200 meters, the deep ocean, and the upper 10 centimeters of deep ocean sediments.

Soil was divided into forest and non-forest types. The researchers then used detailed direct measurements from two studies representative of these soil types to calculate the total number of soil bacteria. Only nine data sets were available for the subsurface, but Whitman used indirect evidence to complete the picture of subsurface bacteria.

"We estimated that about 92 to 94 percent of the Earth's prokaryotes are in the soil subsurface," said Whitman. "We consider the subsurface to include marine sediments below about four inches and terrestrial habitats below about 30 feet."

Another important part of the study was an estimate of carbon content in bacteria. Carbon, of course, is a crucial element in numerous natural processes, so kno
'"/>

Contact: Phil Williams
philwpio@arches.uga.edu
(706) 542-8501
University of Georgia
24-Aug-1998


Page: 1 2 3

Related biology news :

1. Three Institutions Combine Efforts In First-Ever Demonstration Of Long-Term Function In Transplanted Human Liver Cells
2. 2nd media alert First Scientific Conference on Childhood Leukaemia
3. First International Scientific Conference on Childhood Leukaemia
4. Scientific publications: Time for change
5. Dr. Walter Reich, Ph.D., receives prestigious AAAS 2003 Scientific Freedom and Responsibility Award
6. Press briefings at The Gerontological Society of Americas 56th Annual Scientific Meeting
7. Scientific study of twins shows forgiveness has genetic component
8. Scientific equipment including the first European student experiment reaches the ISS
9. Emorys CancerQuest wins top Web award from Scientific American
10. Scientific innovations, social issues and biobusiness at Bio Tech Helsinki 03
11. Scientific balancing act dominates AAAS top ten list of science policy stories for 2002

Post Your Comments:
(Date:11/21/2014)... According to a new market research report ... Control, Intrusion Detection, Parking Management, Under Vehicle Inspection), End ... - Global Forecasts to 2020", published by MarketsandMarkets, The ... $25 Billion in 2014 and is expected to reach ... 8.69%. Browse 116 market data Tables and ...
(Date:11/21/2014)... JOSE, Calif. , Nov. 20, 2014   ... global leader in microcontroller (MCU) and touch technology solutions, ... digital temperature sensors with the widest V cc ... delivers higher temperature accuracy and faster I 2 C ... registers and serial EEPROM memory making them ideal for ...
(Date:11/18/2014)... YORK , Nov. 18, 2014   ... identity authentication solutions, and MorphoTrust USA ... and services, today announced a strategic partnership to ... enterprise, motor vehicle administration (MVA), airport screening and ... in identity-related solutions, MorphoTrust serves consumers through a ...
Breaking Biology News(10 mins):Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3
(Date:12/17/2014)... Ipsen Biopharmaceuticals, Inc., an affiliate ... IPSEY), today announced that Somatuline® Depot® (lanreotide) ... approved by the U.S. Food and Drug Administration ... (GEP-NETs) in adult patients with unresectable, well or ... improve progression-free survival (PFS). , “The approval of ...
(Date:12/17/2014)... IN (PRWEB) December 17, 2014 ... Laboratory Excellence following its most recent COLA inspection. ... by COLA, a national healthcare accreditation organization. Accreditation ... standards of quality in day-to-day operations, demonstrate continued ... pass a rigorous on-site laboratory survey. ...
(Date:12/17/2014)... 2014  Vermillion, Inc. (NASDAQ: VRML ), ... announced the next step in its expanded strategy to ... with the naming of current Chief Operating Officer, ... while current Chairman of the Board and CEO ... These changes are effective January 1, 2015. ...
(Date:12/17/2014)... 17, 2014 Tigercat Pharma, Inc. today ... evaluating the investigational oral NK-1 receptor antagonist VPD-737 ... chronic itch who are unresponsive or inadequately responsive ... steroids and antihistamines. The primary ... Scale (VAS) itch score from baseline, comparing drug ...
Breaking Biology Technology:Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8Xeno Diagnostics Receives 3rd Award for Laboratory Excellence 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4
Cached News: